TELETRADER News
6/3, 8:15 AM (Source: TeleTrader)
more TeleTrader news

Seoul to invest $82M in antiviral treatment plans

South Korea's Health Minister Park Neung-hoo announced on Wednesday that the government will allocate 100 billion won ($82 million) to the development plans for COVID-19 treatment.

The program will focus on producing local plasma treatment for the disease before the end of 2020, while the health authorities are gathering blood samples of people who have recovered. Seoul is cooperating with domestic biotech firms on the plan in order to begin clinical testing in the next two to three months.

Antibody treatment is another point of emphasis for the South Korean government, with the second half of the year being planned for human testing. The health authorities are also evaluating the reportedly high antiviral efficacy of Nafamostat therapy.

Breaking the News / MS